Your browser doesn't support javascript.
loading
Splenic Infarction as the Initial Manifestation of Antiphospholipid Syndrome in a Systemic Lupus Erythematosus Patient / 대한내과학회지
Korean Journal of Medicine ; : 651-654, 2014.
Artículo en Coreano | WPRIM | ID: wpr-151946
ABSTRACT
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease. In patients with SLE, the prevalence of antiphospholipid antibodies is considerably higher, and is largely responsible for thrombosis. Splenic infarction is a rare complication of arterial thrombosis in patients with SLE. It is important to consider splenic infarction in a patient with SLE complaining of left upper quadrant (LUQ) pain because of the possibility of severe infarction-related complications, such as subcapsular hemorrhage and splenic rupture. We report a case of solitary splenic infarction in a patient with SLE. The only symptom was LUQ pain of 3-day duration. Lupus anticoagulant activity was positive and abdominal-pelvic computed tomography (CT) was consistent with splenic infarction. She did not show any other evidence of thrombotic events. The patient was diagnosed with antiphospholipid syndrome that presented as a splenic infarction in a SLE patient.
Asunto(s)

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Enfermedades Autoinmunes / Infarto del Bazo / Rotura del Bazo / Trombosis / Prevalencia / Inhibidor de Coagulación del Lupus / Síndrome Antifosfolípido / Anticuerpos Antifosfolípidos / Hemorragia / Lupus Eritematoso Sistémico Tipo de estudio: Estudio de prevalencia Límite: Humanos Idioma: Coreano Revista: Korean Journal of Medicine Año: 2014 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Enfermedades Autoinmunes / Infarto del Bazo / Rotura del Bazo / Trombosis / Prevalencia / Inhibidor de Coagulación del Lupus / Síndrome Antifosfolípido / Anticuerpos Antifosfolípidos / Hemorragia / Lupus Eritematoso Sistémico Tipo de estudio: Estudio de prevalencia Límite: Humanos Idioma: Coreano Revista: Korean Journal of Medicine Año: 2014 Tipo del documento: Artículo